Oxaliplatin-Induced Neuropathy in Colorectal Cancer
Oxaliplatin use in palliative and adjuvant treatment of colon cancer is frequently limited by cumulative neurotoxicity, leading to reduced quality of life and decreased dose. The mechanism of this neurotoxicity is unclear, but may relate to neuronal voltage-gated sodium channels involving calcium ch...
Main Authors: | Andrew Weickhardt, Keith Wells, Wells Messersmith |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2011/201593 |
Similar Items
-
Oxaliplatin-Induced Peripheral Neuropathy Grade in Females with Colorectal Cancer Patients
by: Inas Moawya Ahmed, et al.
Published: (2019-06-01) -
Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
by: Naohisa Yoshida, et al.
Published: (2013-01-01) -
Peripheral neuropathy – complication after oxaliplatin-based chemotherapy
for colorectal cancer. Preliminary report
by: Marta Banach, et al.
Published: (2015-12-01) -
Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
by: Guido Cavaletti, et al.
Published: (2020-05-01) -
Oxaliplatin induces oxidative stress in colorectal cancer cells
by: 陳珮沂